Green Cross Medical Science Corporation (KOSDAQ:142280)
South Korea
· Delayed Price · Currency is KRW 3,615.00
-85.00 (-2.30%)
At close: Mar 31, 2025, 3:30 PM KST
KOSDAQ:142280 Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Other Revenue | -0 | - | -0 | - | 0 | Upgrade
|
| Revenue | 103,852 | 94,011 | 113,109 | 101,675 | 113,377 | Upgrade
|
| Revenue Growth (YoY) | 10.47% | -16.89% | 11.25% | -10.32% | 39.13% | Upgrade
|
| Cost of Revenue | 89,086 | 80,056 | 100,363 | 100,043 | 93,601 | Upgrade
|
| Gross Profit | 14,767 | 13,955 | 12,746 | 1,631 | 19,777 | Upgrade
|
| Selling, General & Admin | 8,080 | 7,708 | 10,051 | 11,399 | 11,946 | Upgrade
|
| Research & Development | 3,383 | 2,880 | 2,167 | 2,134 | 2,654 | Upgrade
|
| Other Operating Expenses | 75.96 | 77.02 | 95.84 | 92.43 | 70.07 | Upgrade
|
| Operating Expenses | 12,506 | 12,683 | 14,554 | 21,795 | 15,578 | Upgrade
|
| Operating Income | 2,261 | 1,272 | -1,808 | -20,164 | 4,199 | Upgrade
|
| Interest Expense | -2,824 | -3,309 | -2,875 | -1,172 | -466.8 | Upgrade
|
| Interest & Investment Income | 158.13 | 273.96 | 394.85 | 26.27 | 46 | Upgrade
|
| Currency Exchange Gain (Loss) | -35.14 | -14.87 | 41.89 | 53.98 | -140.66 | Upgrade
|
| Other Non Operating Income (Expenses) | 5,215 | 4,050 | 641.81 | 89.11 | 3,439 | Upgrade
|
| EBT Excluding Unusual Items | 4,774 | 2,272 | -3,605 | -21,167 | 7,076 | Upgrade
|
| Gain (Loss) on Sale of Investments | -428.89 | -396.55 | 650.69 | 49.98 | 34.56 | Upgrade
|
| Gain (Loss) on Sale of Assets | -210.98 | -9.99 | 3.55 | 8.38 | 127.23 | Upgrade
|
| Other Unusual Items | -738.52 | - | - | - | - | Upgrade
|
| Pretax Income | 3,396 | 1,865 | -2,951 | -21,108 | 7,238 | Upgrade
|
| Income Tax Expense | -0.51 | -11.34 | 108.07 | 29.84 | 210.74 | Upgrade
|
| Earnings From Continuing Operations | 3,396 | 1,877 | -3,059 | -21,138 | 7,027 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | 162.96 | Upgrade
|
| Net Income to Company | 3,396 | 1,877 | -3,059 | -21,138 | 7,190 | Upgrade
|
| Minority Interest in Earnings | 184.63 | -79.45 | -521.86 | -64.04 | -473.11 | Upgrade
|
| Net Income | 3,581 | 1,797 | -3,581 | -21,202 | 6,717 | Upgrade
|
| Net Income to Common | 3,581 | 1,797 | -3,581 | -21,202 | 6,717 | Upgrade
|
| Net Income Growth | 99.25% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 87 | 24 | 21 | 21 | 21 | Upgrade
|
| Shares Change (YoY) | 269.34% | 12.19% | 0.05% | - | 90.86% | Upgrade
|
| EPS (Basic) | 168.00 | 85.00 | -169.87 | -1006.40 | 318.83 | Upgrade
|
| EPS (Diluted) | 41.00 | 76.00 | -170.00 | -1006.40 | 318.83 | Upgrade
|
| EPS Growth | -46.05% | - | - | - | - | Upgrade
|
| Free Cash Flow | 445.24 | -1,391 | 7,454 | -21,793 | -11,314 | Upgrade
|
| Free Cash Flow Per Share | 5.10 | -58.80 | 353.61 | -1034.47 | -537.04 | Upgrade
|
| Gross Margin | 14.22% | 14.84% | 11.27% | 1.60% | 17.44% | Upgrade
|
| Operating Margin | 2.18% | 1.35% | -1.60% | -19.83% | 3.70% | Upgrade
|
| Profit Margin | 3.45% | 1.91% | -3.17% | -20.85% | 5.92% | Upgrade
|
| Free Cash Flow Margin | 0.43% | -1.48% | 6.59% | -21.43% | -9.98% | Upgrade
|
| EBITDA | 6,047 | 5,125 | 2,299 | -16,333 | 7,361 | Upgrade
|
| EBITDA Margin | 5.82% | 5.45% | 2.03% | -16.06% | 6.49% | Upgrade
|
| D&A For EBITDA | 3,786 | 3,854 | 4,107 | 3,831 | 3,162 | Upgrade
|
| EBIT | 2,261 | 1,272 | -1,808 | -20,164 | 4,199 | Upgrade
|
| EBIT Margin | 2.18% | 1.35% | -1.60% | -19.83% | 3.70% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 2.91% | Upgrade
|
| Advertising Expenses | 346.48 | 99.73 | 156.14 | 198.06 | 120.84 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.